NEWS & INSIGHTS - 2022
parade.ai
Nov 1, 2022
Parade Releases New Products to Further Improve Freight Brokerage Efficiency and the Bottom Line
intervenn biosciences
Oct 6, 2022
InterVenn Biosciences Co-Founder Carolyn Bertozzi Awarded Nobel Prize in Chemistry
synthex
Oct 4, 2022
SyntheX and Bristol Myers Squibb Partner on Drug Development Deal Worth up to $550M
double rainbow
Aug 22, 2022
DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound therapeutics
ayla networks
July 27, 2022
Ayla Networks Announces Support for Smart Home Device Developers Adopting the Matter Standard
intervenn biosciences
July 22, 2022
InterVenn expands globally to drive the potential of glycoproteomics to improve patient outcomes
aromyx
July 16, 2022
High-Tech Smell Sensors Aim to Sniff Out Disease, Explosives—and Even Moods
kepler communications
June 9, 2022
Kepler selects Tesat to provide optical terminals for next-gen constellation
auryc
June 1, 2022
A New Start for Auryc: Joining Heap to Transform the Online Experience!
teon therapeutics
June 1, 2022
Teon Therapeutics Announces FDA Acceptance of IND Application for Novel, Oral Immune Checkpoint Inhibitor, TT-816
teon therapeutics
point card
parade.ai
Feb 9, 2022
Parade raises $12.7M to ‘speed up tech enablement for freight brokers’
kepler communications